Many cancers and rare diseases have origins in our DNA. A team of UNC faculty from many scientific backgrounds are converging around the field of epigenetics to rewrite faulty instructions by delivering chemical compounds to our genome – to treat genetic diseases without changing the DNA itself.

Interdisciplinary faculty research designed to tackle compelling problems is finding support from the Institute for Convergent Science in the Genome Sciences Building on campus. The goal: Expediting the research-to-marketplace pipeline.

A UNC biomedical engineering professor’s knack for entrepreneurial resourcefulness helped him jumpstart the development of an innovative face mask device – and a new startup company.